Oliver Kubli
Portefeuillebeheerder-Aandelen bij Bellevue Asset Management AG
Oorsprong van het eerstegraads netwerk van Oliver Kubli
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Bellevue Asset Management AG
 Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.
34
| Subsidiary | Investment Managers | 34 |
Zürcher Kantonalbank (Investment Management)
 Zürcher Kantonalbank (Investment Management) Investment ManagersFinance Zürcher Kantonalbank (Investment Management) (ZKB-IM) is the investment management division of Zürcher Kantonalbank, a Swiss full-service bank headquartered in Zurich. Founded in 1870, ZKB-IM performs the bank's investment activities, including financial advisory services, research, trading, and asset management. The asset management division provides investment solutions for institutional, corporate and private clients, managing discretionary mandates and the ZKB range of mutual funds. Their mission includes fostering economic growth in the Canton of Zurich.
14
| Operating Division | Investment Managers | 14 |
Auris Medical Holding AG /Old/
 Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland.
12
| Extinct | Medical Specialties | 12 |
Zürcher Kantonalbank
 Zürcher Kantonalbank Major BanksFinance Zürcher Kantonalbank engages in the provision of universal banking services. It offers its services through the following divisions: Private Banking, International Banking and Asset Management. The Private Banking division offers private advisory, asset management, fiduciary and other services. The International Banking division provides international payments and trade finance services. The Asset Management division includes segregated, balanced and overlay mandates. It also offers strategy advice and portfolio analysis services. The company was founded on February 15, 1870 and is headquartered in Zürich, Switzerland.
11
| Subsidiary | Major Banks | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Oliver Kubli via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BB BIOTECH AG | Financial Conglomerates | Chief Investment Officer Corporate Officer/Principal | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AcuFocus, Inc.
 AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member | |
Bank Julius Bär & Co. AG
 Bank Julius Bär & Co. AG Investment ManagersFinance Bank Julius Bär & Co. AG (BJB) is the private banking subsidiary of Julius Bär Gruppe AG (SWX: BAER) in Switzerland. Headquartered in Zurich, BJB was founded in 1890 and provides personal wealth management advice to private clients and family offices. | Investment Managers | Portfolio Manager-Equities Analyst-Equity | |
Adams Harkness & Hill Investment Banking
 Adams Harkness & Hill Investment Banking Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Adams Harkness & Hill Investment Banking is a company based in Boston, MA. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| ATON | Pharmaceuticals: Major | Chairman | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| Université de Montpellier | College/University | Doctorate Degree | |
| University of St. Gallen | College/University | Doctorate Degree Doctorate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member | |
| University of Lund | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Zurich | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| University of Geneva | College/University | Graduate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| BELLEVUE GROUP AG | Investment Managers | Director of Finance/CFO Corporate Officer/Principal Chief Investment Officer | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Director/Board Member | |
Vivacta Ltd.
 Vivacta Ltd. Medical SpecialtiesHealth Technology Vivacta Ltd. operates as a medical diagnostics company. It develop point of care diagnostic device and microfluidic cartridge. The company is founded in 2005 and is headquartered in Camberley, the United Kingdom. | Medical Specialties | Director/Board Member | |
| Centre Hospitalier Universitaire Pitie-Salpetriere | College/University | Graduate Degree | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member | |
Umecrine AB
 Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Biotechnology | Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
The Jewish Guild for the Blind
 The Jewish Guild for the Blind Medical/Nursing ServicesHealth Services The Jewish Guild for the Blind engages in the provision of health care services. Its focus areas include healthcare organization with a long standing heritage of addressing the needs of people who are blind or visually impaired, including those with multiple disabilities and chronic medical conditions. The company was founded in 1914 and is headquartered in New York, NY. | Medical/Nursing Services | Chief Executive Officer | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| Kantonsrat des Eidgenössischen Standes Zürich | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| Medesis SA | Director/Board Member | ||
| Amistad Pharma | Chief Executive Officer | ||
Fournier Group, Inc.
 Fournier Group, Inc. Multi-Line InsuranceFinance Part of RSC Insurance Brokerage, Inc., Fournier Group, Inc. is a dynamic independent insurance agency headquartered in Portland, OR. Fournier Group, Inc. provides personal (home/auto/specialty), business, and aviation insurance to diverse clients. The company was founded by Dirk Fournier. Fournier Group was acquired by RSC Insurance Brokerage, Inc. on December 09, 2021. | Multi-Line Insurance | Corporate Officer/Principal | |
Key Neurosciences SAS
 Key Neurosciences SAS Miscellaneous Commercial ServicesCommercial Services Key Neurosciences SAS provides research and development services. Its services include product and technology development, fund raising, business and commercial development, and project management. The company was founded in December 2010 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Chairman | |
| VALNEVA | Biotechnology | Director/Board Member | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
| Science, Business & Management SARL | Chief Executive Officer | ||
| MEDESIS PHARMA S.A. | Biotechnology | Director/Board Member | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Bellevue Asset Management (UK) Ltd.
 Bellevue Asset Management (UK) Ltd. Investment ManagersFinance Bellevue Asset Management (UK) Ltd. (Bellevue AM UK) is an investment management firm headquartered in London, UK. The firm was founded in 2014 and is a subsidiary of Bellevue Asset Management AG, owned by Bellevue Group AG (SWX: BBN) in Switzerland. Bellevue AM UK provides investment advisory and management services to their clients. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities | |
| ALTAMIRA THERAPEUTICS LTD. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer General Counsel | |
| Intercell Austria AG | Director/Board Member | ||
Quantafuel Cheshire Ltd.
 Quantafuel Cheshire Ltd. Environmental ServicesIndustrial Services Quantafuel Cheshire Ltd. is a British waste management company founded in 2021. The private company is based in Cardiff, UK and engages in the treatment and disposal of non-hazardous waste. | Environmental Services | Director/Board Member | |
Fournier Laboratories Ireland Ltd.
 Fournier Laboratories Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Fournier Laboratories Ireland Ltd. is an Irish company that manufactures pharmaceutical preparations. The company is based in Carrigtwohill, Ireland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Zwitserland | 14 |
| Frankrijk | 13 |
| Verenigde Staten | 9 |
| Zweden | 5 |
| Verenigd Koninkrijk | 5 |
Sectoraal
| Health Technology | 25 |
| Finance | 10 |
| Consumer Services | 10 |
| Health Services | 2 |
| Government | 2 |
Operationeel
| Director/Board Member | 176 |
| Portfolio Manager-Equities | 55 |
| Corporate Officer/Principal | 52 |
| Independent Dir/Board Member | 47 |
| Analyst-Equity | 46 |
Sterkste connecties
| Insiders | |
|---|---|
| James Healy | 50 |
| Antoine Papiernik | 48 |
| Alain Munoz | 38 |
| Berndt A. E. Modig | 23 |
| Armando Anido | 16 |
| Mats Blom | 15 |
| Calvin Roberts | 14 |
| Jörg Müller-Ganz | 10 |
| Daniel Koller | 9 |
| Marcel Pfister | 9 |
| Dallas Webb | 9 |
| Sven Zimmermann | 8 |
| Felicia Flanigan | 7 |
| Christian Lach | 7 |
| Thomas Jung | 7 |
- Beurs
- Insiders
- Oliver Kubli
- Bedrijfsconnecties
